• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[胃肠道间质瘤“GIST”:基于我们54例病例经验及文献综述的现状与新进展]

[Gastrointestinal Stromal Tumors "GIST": status and news through our experience on 54 cases and review of literature].

作者信息

Taoufiq Nezha, Naim Asmaa, Bouchbika Zineb, Benchekroune Nadia, Jouhadi Hassan, Sahraoui Souha, Benider Abdelatif

机构信息

Centre Mohamed VI de la Lutte contre le Cancer Casablanca, Maroc.

Université Mohamed VI des Sciences de la Santé UM6SS, Maroc.

出版信息

Pan Afr Med J. 2017 Jun 30;27:165. doi: 10.11604/pamj.2017.27.165.7754. eCollection 2017.

DOI:10.11604/pamj.2017.27.165.7754
PMID:28904693
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5567940/
Abstract

Tumors Gastrointestinal Stromal "GIST" are a very rare form of digestive tract cancers belonging to the family of sarcomas. The aim of this study is to establish the epidemiological profile, the diagnostic and therapeutic difficulties of this malignancy supported in a developing country. A retrospective study spread over 8 years from January 2002 to March 2010, was conducted at the Department of Radiotherapy and Oncology of Casablanca (Morocco) have collated 54 cases of Gastrointestinal Stromal tumors. The average age of our patients was 55 years. The average time of evolution was 11 months (0-72 months). The biopsy confirmed the diagnosis in 14 cases and surgery in 40 cases. The main histological form was fusiform (92.6%). GIST in our series had an average tumor size of 12.5 cm with a positive C-Kit in 52 cases. The risk of progression was established in 47 cases of which 39 were high risk. Surgery was the main treatment of patients in our study. After a mean fellow of 31 months, half of evaluable patients in our series (n = 19) is maintained complete remission, one third (n= 13) died while a quarter (n= 8) has a local recurrence and / or metastatic. Although the recommendations are published for the treatment of these tumors, these still present many problems both diagnostic and therapeutic in our context.

摘要

胃肠道间质瘤(GIST)是一种非常罕见的消化道癌症,属于肉瘤家族。本研究的目的是确定在一个发展中国家,这种恶性肿瘤的流行病学概况、诊断和治疗难点。在卡萨布兰卡(摩洛哥)放疗与肿瘤学系进行了一项回顾性研究,该研究涵盖了从2002年1月至2010年3月的8年时间,整理出54例胃肠道间质瘤病例。我们患者的平均年龄为55岁。平均病程为11个月(0 - 72个月)。活检确诊14例,手术确诊40例。主要组织学类型为梭形(92.6%)。我们系列中的胃肠道间质瘤平均肿瘤大小为12.5厘米,52例C-Kit呈阳性。47例确定有进展风险,其中39例为高风险。手术是我们研究中患者的主要治疗方式。平均随访31个月后,我们系列中一半的可评估患者(n = 19)维持完全缓解,三分之一(n = 13)死亡,四分之一(n = 8)出现局部复发和/或转移。尽管已经发布了这些肿瘤的治疗建议,但在我们的情况下,这些肿瘤在诊断和治疗方面仍然存在许多问题。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23bd/5567940/fd389bdcdc6c/PAMJ-27-165-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23bd/5567940/bfc6f66b918e/PAMJ-27-165-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23bd/5567940/fd389bdcdc6c/PAMJ-27-165-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23bd/5567940/bfc6f66b918e/PAMJ-27-165-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23bd/5567940/fd389bdcdc6c/PAMJ-27-165-g002.jpg

相似文献

1
[Gastrointestinal Stromal Tumors "GIST": status and news through our experience on 54 cases and review of literature].[胃肠道间质瘤“GIST”:基于我们54例病例经验及文献综述的现状与新进展]
Pan Afr Med J. 2017 Jun 30;27:165. doi: 10.11604/pamj.2017.27.165.7754. eCollection 2017.
2
Clinical presentation, management and outcomes of gastrointestinal stromal tumors.胃肠道间质瘤的临床表现、治疗和结局。
Int J Surg. 2014 Oct;12(10):1127-33. doi: 10.1016/j.ijsu.2014.08.351. Epub 2014 Aug 22.
3
Gastrointestinal stromal tumors (GIST) related emergencies.胃肠道间质瘤(GIST)相关急症。
Int J Surg. 2014;12(4):269-80. doi: 10.1016/j.ijsu.2014.02.004. Epub 2014 Feb 12.
4
The standard diagnosis, treatment, and follow-up of gastrointestinal stromal tumors based on guidelines.基于指南的胃肠道间质瘤的标准诊断、治疗及随访
Gastric Cancer. 2016 Jan;19(1):3-14. doi: 10.1007/s10120-015-0526-8. Epub 2015 Aug 15.
5
[Stromal gastrointestinal tumors: retrospective study of 24 cases].[胃肠道间质瘤:24例回顾性研究]
Tunis Med. 2013 Nov;91(11):661-7.
6
Surgical and medical management of small bowel gastrointestinal stromal tumors: A report of the Dutch GIST registry.小肠胃肠道间质瘤的外科和医学管理:荷兰 GIST 登记处的报告。
Eur J Surg Oncol. 2019 Mar;45(3):410-415. doi: 10.1016/j.ejso.2018.09.013. Epub 2018 Oct 16.
7
Prognostic factors in gastrointestinal stromal tumors: multicenter experience of 333 cases from Turkey.胃肠道间质瘤的预后因素:来自土耳其的333例多中心经验
Hepatogastroenterology. 2013 Jun;60(124):768-75. doi: 10.5754/hge11666. Epub 2012 Nov 20.
8
Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis.伊马替尼治疗后初始不可切除的胃肠道间质瘤患者切除标本中CD117表达降低作为复发可能预后标志物的临床病理分析
Anticancer Drugs. 2008 Jul;19(6):607-12. doi: 10.1097/CAD.0b013e32830138f9.
9
Increased risk of additional cancers among patients with gastrointestinal stromal tumors: A population-based study.胃肠道间质瘤患者发生其他癌症的风险增加:一项基于人群的研究。
Cancer. 2015 Sep 1;121(17):2960-7. doi: 10.1002/cncr.29434. Epub 2015 Apr 30.
10
Gastrointestinal stromal tumor--background, pathology, treatment.胃肠道间质瘤——背景、病理、治疗。
Hematol Oncol Clin North Am. 2012 Dec;26(6):1239-59. doi: 10.1016/j.hoc.2012.08.003.

引用本文的文献

1
[Gastrointestinal stromal tumors: a retrospective study].[胃肠道间质瘤:一项回顾性研究]
Pan Afr Med J. 2023 Jun 21;45:97. doi: 10.11604/pamj.2023.45.97.36563. eCollection 2023.
2
C-kit-negative transmural gastrointestinal stromal tumor in the stomach: A rare case of upper GI bleeding in Ghana.胃中C-kit阴性透壁性胃肠道间质瘤:加纳上消化道出血的罕见病例。
Clin Case Rep. 2023 Feb 3;11(2):e6906. doi: 10.1002/ccr3.6906. eCollection 2023 Feb.
3
Challenge of gastro-intestinal stromal tumor management in low-income countries: example of Benin.

本文引用的文献

1
Pharmacological management of gastrointestinal stromal tumours: an update on the role of sunitinib.胃肠道间质瘤的药物治疗管理:舒尼替尼作用的最新进展。
Ann Oncol. 2010 Feb;21(2):208-215. doi: 10.1093/annonc/mdp291. Epub 2009 Aug 12.
2
Gastrointestinal stromal tumors: pathology and prognosis at different sites.胃肠道间质瘤:不同部位的病理学与预后
Semin Diagn Pathol. 2006 May;23(2):70-83. doi: 10.1053/j.semdp.2006.09.001.
3
Gastrointestinal stromal tumors (GIST).胃肠道间质瘤
低收入国家胃肠道间质瘤管理的挑战:以贝宁为例。
World J Surg Oncol. 2022 Dec 1;20(1):247. doi: 10.1186/s12957-022-02709-9.
Gastroenterol Clin Biol. 2006 Sep;30 Spec No 2:2S98-2S101.
4
Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial.舒尼替尼在伊马替尼治疗失败的晚期胃肠道间质瘤患者中的疗效与安全性:一项随机对照试验
Lancet. 2006 Oct 14;368(9544):1329-38. doi: 10.1016/S0140-6736(06)69446-4.
5
Gastrointestinal stromal tumors of the jejunum and ileum: a clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up.空肠和回肠胃肠道间质瘤:伊马替尼治疗前906例的临床病理、免疫组织化学及分子遗传学研究并长期随访
Am J Surg Pathol. 2006 Apr;30(4):477-89. doi: 10.1097/00000478-200604000-00008.
6
KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours.晚期胃肠道间质瘤患者的KIT突变与伊马替尼剂量选择
Eur J Cancer. 2006 May;42(8):1093-103. doi: 10.1016/j.ejca.2006.01.030. Epub 2006 Apr 18.
7
Co expression of SCF and KIT in gastrointestinal stromal tumours (GISTs) suggests an autocrine/paracrine mechanism.干细胞因子(SCF)和干细胞生长因子受体(KIT)在胃肠道间质瘤(GISTs)中的共表达提示了一种自分泌/旁分泌机制。
Br J Cancer. 2006 Apr 24;94(8):1180-5. doi: 10.1038/sj.bjc.6603063.
8
[Gastrointestinal stromal tumors: definition, histological, immunohistochemical, and molecular features, and diagnostic strategy].[胃肠道间质瘤:定义、组织学、免疫组化及分子特征与诊断策略]
Ann Pathol. 2005 Oct;25(5):358-85; quiz 357. doi: 10.1016/s0242-6498(05)80145-2.
9
Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO.胃肠道间质瘤管理共识会议。2004年3月20 - 21日在欧洲肿瘤内科学会(ESMO)主持下召开的胃肠道间质瘤共识会议报告。
Ann Oncol. 2005 Apr;16(4):566-78. doi: 10.1093/annonc/mdi127.
10
Analysis of prognostic and immunohistochemical factors in gastrointestinal stromal tumors with malignant potential.具有恶性潜能的胃肠道间质瘤的预后及免疫组化因素分析
J Gastrointest Surg. 2005 Mar;9(3):418-29. doi: 10.1016/j.gassur.2004.07.003.